Enhabit (EHAB) EVP granted shares and surrenders stock for taxes

Rhea-AI Filing Summary

Enhabit, Inc. executive Julie Diane Jolley, EVP of Home Health Operations, reported routine equity compensation activity. On March 6, she received a grant of 10,030 shares of common stock at $13.61 per share. On March 6 and 7, a total of 6,608 shares were disposed of at the same price to cover tax withholding obligations tied to restricted stock vesting, as noted in the footnote. After these transactions, she directly holds 130,666 shares of Enhabit common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jolley Julie Diane

(Last) (First) (Middle)

6688 N. CENTRAL EXPRESSWAY

SUITE 1300

(Street)

DALLAS TX 75206

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enhabit, Inc. [ EHAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP of Home Health Operations

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		A		10,030	A	$13.61	137,274	D
Common Stock	03/06/2026		F		3,646(1)	D	$13.61	133,628	D
Common Stock	03/07/2026		F		2,962(1)	D	$13.61	130,666	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

Remarks:

	/s/ Sarah W. Braley, Attorney in Fact	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Enhabit (EHAB) EVP Julie Jolley report?

Julie Jolley reported a stock grant and related tax withholding transactions. She received 10,030 Enhabit common shares at $13.61 per share, with 6,608 shares surrendered on March 6 and 7 to cover tax obligations from restricted stock vesting.

How many Enhabit (EHAB) shares were granted to EVP Julie Jolley?

She was granted 10,030 shares of Enhabit common stock at $13.61 per share on March 6. This grant is classified as a compensation-related acquisition rather than an open-market purchase, increasing her direct equity stake in the company.

Were Julie Jolley’s Enhabit (EHAB) Form 4 transactions open-market sales?

No. The Form 4 shows F-code transactions that are tax-withholding dispositions, not open-market sales. A total of 6,608 shares were withheld or surrendered to satisfy tax obligations triggered by the vesting of restricted stock, according to the filing’s footnote.

How many Enhabit (EHAB) shares does EVP Julie Jolley own after these transactions?

Following the reported grant and tax-withholding dispositions, Julie Jolley directly holds 130,666 shares of Enhabit common stock. This figure reflects her position after the March 7 transaction and provides context for the relative size of the reported equity movements.

What is the significance of the F code in Julie Jolley’s Enhabit (EHAB) Form 4?

The F code indicates shares used to pay taxes or exercise costs, not discretionary selling. In this case, 6,608 shares of Enhabit stock were withheld or surrendered solely to cover tax liabilities from restricted stock vesting, as specifically described in the footnote.